"US transcatheter tricuspid valve repair market grows by over 50% since launch in Q2 2024" was originally created and ...

Patients with cryptogenic stroke treated with routine transcatheter patent foramen ovale closure have increased 4-year stroke risk.

A new study published in the New England Journal of Medicine showed that improvements in symptoms and quality of life were ...

In a trial that many are calling landmark, transcatheter aortic valve replacement had better outcomes than surveillance for ...

The Global Transcatheter Cardiac Valve Replacement (THVR) Market, valued at USD 6.54 billion in 2023, is anticipated to grow significantly with a CAGR of 14.8% over the forecast period of 2024 to 2032 ...

For patients with symptomatic and severe tricuspid regurgitation (TR), tricuspid transcatheter edge-to-edge repair (T-TEER) ...

For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement ...

The NOTION-3 study investigated if routine revascularization with PCI and transcatheter aortic valve replacement improves ...

Implantation of the Ventura interatrial shunt, while safe, does not improve clinical outcomes or prognosis in patients with HF and preserved LVEF.

The ACCESS-TAVI trial demonstrated that a combined suture/plug-based vascular closure device strategy significantly reduces ...

The contest between the two main classes of antiproliferatives for circulatory system use continues as seen in a presentation ...